The RNP complex is the influenza virus’s essential package, the virus’s blueprints and a copy machine all rolled in one. The ...

Study Shows Drop in Use of Antiviral Medications in Young Children With Influenza Dec. 17, 2024 — Despite national medical guidelines supporting the use of antiviral medications in young ...

Scientists create the world’s largest bat organoid platform—offering new tools to study viruses and boost pandemic ...

More than 75% of new infectious diseases affecting humans originally come from animals. Bats, in particular, are natural ...

MPox is endemic in DRC, and has continued to cause large numbers of cases in the WHO African Region. In April, 2025, the WHO has restated that MPox continues to be a Public Health Emergency of ...

the CDC recommends that treatment with prescription flu antiviral drugs “should be started as early as possible and are especially important for patients at higher risk for severe illness.” ...

NanoViricides, Inc. (NYSE American: NNVC) filed its Q1 2025 report and announced progress on NV-387, its broad-spectrum antiviral drug candidate. The ...

CDC reports 216 children have died from flu this season, the highest since 2009, with 47 million total cases nationwide ...

In vitro testing with CDI-988 demonstrated superior broad-spectrum antiviral activity against major norovirus variants BOTHELL, W ...

The global antiviral drugs market is poised for steady expansion, projected to reach a valuation of USD 89.68 billion by 2033, up from USD 61.42 billion in 2023, growing at a Compound Annual Growth ...

New research by scientists at the University of Toronto and the Structural Genomics Consortium has deepened our understanding ...

“Our novel, broad-spectrum drug candidates have the potential to ... biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza ...